Business article - December 17, 2024
Key takeaways from the EU HTA panel discussion in Finland
With just months to go before the EU joint clinical assessment (JCA) process takes effect, the focus on what it will mean from a country perspective is intensifying.
Biotech Business - December 6, 2024
Cyxone files for bankruptcy
The company has decided to file for bankruptcy in order to manage the financial situation that has arisen.
Business article - December 4, 2024
4 x Pilot projects in BRIDGE
BRIDGE Sweden aims to streamline the journey from research to commercialization in biologics and precision medicine. Four pharmaceutical pilot projects will play a pivotal role in advancing this initiative.
Biotech Business - November 26, 2024
CELLINK announces right-sizing and sharpened commercial agenda
The rightsizing is expected to result in redundancy of approximately 20 percent of the employees across the CELLINK organization.
Biotech Business - November 13, 2024
Evaxion receives and appeals delisting determination from Nasdaq
Evaxion Biotech has, as anticipated, received a letter dated November 11, 2024, with a delisting determination from Nasdaq Stock Market LLC for failure to maintain stockholders’ equity of at least USD 2.5 million as required by Nasdaq Listing Rule 5550(b).
Business article - November 6, 2024
Elypta joins the European Innovation Council (EIC) Scaling Club
The EIC Scaling Club is an accelerators and features more than 120 of the EU’s most innovative deep tech scaleups.
